These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8823423

  • 1. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
    S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
    [Abstract] [Full Text] [Related]

  • 2. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [Abstract] [Full Text] [Related]

  • 3. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [Abstract] [Full Text] [Related]

  • 4. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
    Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
    [Abstract] [Full Text] [Related]

  • 5. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
    Tubercle; 1983 Sep; 64(3):153-66. PubMed ID: 6356538
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M.
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [Abstract] [Full Text] [Related]

  • 7. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [Abstract] [Full Text] [Related]

  • 8. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
    [Abstract] [Full Text] [Related]

  • 9. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
    Tubercle; 1975 Jun; 56(2):81-96. PubMed ID: 1103400
    [Abstract] [Full Text] [Related]

  • 10. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study.
    Tubercle; 1980 Jun; 61(2):59-69. PubMed ID: 6159711
    [Abstract] [Full Text] [Related]

  • 11. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK.
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [Abstract] [Full Text] [Related]

  • 12. Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
    Balasubramanian R, Sivasubramanian S, Vijayan VK, Ramachandran R, Jawahar MS, Paramasivan CN, Selvakumar N, Somasundaram PR.
    Tubercle; 1990 Dec; 71(4):253-8. PubMed ID: 2125153
    [Abstract] [Full Text] [Related]

  • 13. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [Abstract] [Full Text] [Related]

  • 14. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun 30; 1(8131):1361-3. PubMed ID: 87829
    [Abstract] [Full Text] [Related]

  • 15. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb 30; 123(2):165-70. PubMed ID: 7015933
    [Abstract] [Full Text] [Related]

  • 16. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1979 Apr 30; 119(4):579-85. PubMed ID: 375787
    [Abstract] [Full Text] [Related]

  • 17. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Hong Kong Chest Service/British Medical Research Council.
    Tubercle; 1982 Jun 30; 63(2):89-98. PubMed ID: 6758252
    [Abstract] [Full Text] [Related]

  • 18. Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study.
    Tubercle; 1991 Jun 30; 72(2):88-100. PubMed ID: 1949222
    [Abstract] [Full Text] [Related]

  • 19. Controlled clinical trial of three short-course regimens of chemotherapy for pulmonary tuberculosis in Nigeria--a preliminary report.
    Onadeko BO, Awotedu AA, Ogunbanjo BO, Aderinto EB.
    Tubercle; 1986 Sep 30; 67(3):189-95. PubMed ID: 3535187
    [Abstract] [Full Text] [Related]

  • 20. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.
    Trop Med Int Health; 2005 Nov 30; 10(11):1090-8. PubMed ID: 16262733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.